# Arsanis funding: rounds and investors

> Arsanis has raised $76M across 4 rounds since 2010. Investors include OrbiMed, Polaris Partners and SV Life Sciences. Every round with its source.

Source: https://millionrounds.com/company/arsanis (Millionrounds; every figure on the page links to its filing or article)

Austria · [Series D startup](https://millionrounds.com/companies)

# Who invested in *Arsanis*

4 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech Healthcare

Funding summary Updated 26 Oct 2026

**$76M** raised across 4 rounds since 2010, from 4 sources

**$400K** Venture **$10M** Series A **$20M** Series B **$46M** Series D

- **Latest round:** Series D, $46M Apr 2017
- **Step-up i:** 2.3×
- **Investors:** 9

See who backed them

## The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2011 2012 2013 2014 2015 2016 2017

**$400K** Venture

**$10M** Series A

**$20M** Series B

**$46M** Series D

- **First round:** Venture, $400K
- **Biggest round:** $46M
- **Usual gap between rounds:** 2.5 years

## The rounds

- **Apr 2017** Series D **$46M** *5 new* *2 returning* [OrbiMed](https://millionrounds.com/fund/orbimed) [Alexandria Real Estate Equities](https://millionrounds.com/fund/alexandria) [NeoMed](https://millionrounds.com/fund/neomed) [Goldbell Group](https://millionrounds.com/fund/polaris) [EMBL Ventures](https://millionrounds.com/fund/embl-ventures) Bill & Melinda Gates Foundation/ GV SV Reported by FinSMEs SEC filing: $46M sold, first sale Apr 2017
- **Sept 2013** Series B **$20M** *1 new* *3 returning* [Polaris Partners](https://millionrounds.com/fund/polaris-partners) [OrbiMed](https://millionrounds.com/fund/orbimed) [SV Life Sciences](https://millionrounds.com/fund/sv-life-sciences) [NeoMed](https://millionrounds.com/fund/neomed) Reported by biospace.com SEC filing: $13M sold, first sale Jul 2013
- **Feb 2011** Series A **$10M** *3 new* [Polaris Partners](https://millionrounds.com/fund/polaris-partners) [OrbiMed](https://millionrounds.com/fund/orbimed) [SV Life Sciences](https://millionrounds.com/fund/sv-life-sciences) Reported by news-medical.net SEC filing: $9.6M sold, first sale Jan 2011
- **Sept 2010** Venture **$400K** No investor was named in the report. From a historical funding record SEC filing: $400K sold, first sale Sept 2010

## Founders and team

From the SEC filings it signed: 5 on the team.

- **Chris U. Stevens** Executive Officer i
- **David U. Mantus** Executive Officer i
- **Eszter U. Nagy** Executive Officer i
- **Michael Gray** Executive Officer i
- **Rene Russo** Executive Officer, Director i

On the board, as filed i *Amy U. Schulman* *Carl U. Gordon* *Claudio U. Nessi* *David U. McGirr* *Michael U. Ross* *Terrance U. McGuire* *Tillman U. Gerngross* *William U. Clark*

## Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

**Venture** 2010 **Series A** 2011 **Series B** 2013 **Series D** 2017 [OrbiMed](https://millionrounds.com/fund/orbimed) [Polaris Partners](https://millionrounds.com/fund/polaris-partners) [SV Life Sciences](https://millionrounds.com/fund/sv-life-sciences) [NeoMed](https://millionrounds.com/fund/neomed) [Alexandria Real Estate Equities](https://millionrounds.com/fund/alexandria) [Goldbell Group](https://millionrounds.com/fund/polaris) [EMBL Ventures](https://millionrounds.com/fund/embl-ventures) Bill & Melinda Gates Foundation/ GV SV

## Everyone who backed them

[OrbiMed](https://millionrounds.com/fund/orbimed) Private equity **3** rounds

[Polaris Partners](https://millionrounds.com/fund/polaris-partners) VC firm **2** rounds

[SV Life Sciences](https://millionrounds.com/fund/sv-life-sciences) VC firm **2** rounds

[NeoMed](https://millionrounds.com/fund/neomed) Growth equity **2** rounds

[Alexandria Real Estate Equities](https://millionrounds.com/fund/alexandria) VC firm **1** round

[Goldbell Group](https://millionrounds.com/fund/polaris) Growth equity **1** round

[EMBL Ventures](https://millionrounds.com/fund/embl-ventures) VC firm **1** round

Bill & Melinda Gates Foundation/ GV no record of our own yet **1** round

SV no record of our own yet **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=arsanis).

## Quick answers about Arsanis

### Who invested in Arsanis?

Arsanis's investors include OrbiMed, Polaris Partners, SV Life Sciences, NeoMed and Alexandria Real Estate Equities, and 4 more on record.

### How much has Arsanis raised?

Arsanis has raised $76M across 4 rounds since 2010.

### When did Arsanis last raise?

Arsanis's most recent round was a Series D of $46M in Apr 2017.

### What was Arsanis's biggest round?

Its most recent round, $46M in Apr 2017, is also its largest on record.

### Who backed Arsanis first?

Arsanis's first round on record, in Feb 2011, was backed by Polaris Partners, OrbiMed and SV Life Sciences.

### What stage is Arsanis at?

Arsanis's latest named round is a Series D, in Apr 2017.

### Where is Arsanis based?

Arsanis is based in Austria.

## Companies like Arsanis

In the same sector, and raised in the last eighteen months.

[**PureSurf** $1.8M · Sept 2026](https://millionrounds.com/company/puresurf)[**SOMAREALITY** $6.2M · Jun 2026](https://millionrounds.com/company/somareality)[**VALANX Biotech** $3.5M · Mar 2026](https://millionrounds.com/company/valanx-biotech)[**Flinn.ai** $20M · Feb 2026](https://millionrounds.com/company/flinn-ai)[**piur imaging** $6.6M · Jul 2025](https://millionrounds.com/company/piur-imaging)[**Coherence Neuro** $55M · Oct 2026](https://millionrounds.com/company/coherence-neuro)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app
